Humoral Response in Hemodialysis Patients Following COVID-19 Vaccination and Breakthrough Infections during Delta and Omicron Variant Predominance

Background: The advancement of COVID-19 vaccination programs globally has been viewed as an integral strategy to reduce both the number of COVID-19 cases and consequential complications of COVID-19, particularly for high-risk patient groups. There are limited data on the antibody response and protec...

Descripción completa

Detalles Bibliográficos
Autores principales: Chinnadurai, Rajkumar, Wu, Henry H. L., Cox, Eleanor, Moore, Jayne, Clough, Toni, Lamerton, Elizabeth, Donne, Rosie, O’Riordan, Edmond, Poulikakos, Dimitrios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028840/
https://www.ncbi.nlm.nih.gov/pubmed/35455248
http://dx.doi.org/10.3390/vaccines10040498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028840/
https://www.ncbi.nlm.nih.gov/pubmed/35455248
http://dx.doi.org/10.3390/vaccines10040498

Ejemplares similares